MedPath

Comparison of Albumin and Cabergoline in the Prevention of Ovarian Hyperstimulation Syndrome

Not Applicable
Conditions
ovariab hyperstimulation.
?????? ??? ????? ?? ?????? ??????-??????
N99-N99
Registration Number
IRCT138706281217N4
Lead Sponsor
Medical Faculty, Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
95
Inclusion Criteria

The inclusion criterion was the presence of >20 oocytes during oocyte retrieval, ovary size>10 cm, serum Estradiol >2500 pg/ml on the day of HCG administration.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Prevention of OHSS. Timepoint: from strat to 2 months later. Method of measurement: questionare.
Secondary Outcome Measures
NameTimeMethod
Severity of OHSS. Timepoint: from start to 15 days later. Method of measurement: questionare.
© Copyright 2025. All Rights Reserved by MedPath